Carbon Biosciences
Amy Lurier is the Senior Vice President of People and Talent at Carbon Biosciences. She brings over 35 years of experience spanning start-up biotech, biopharma and medical device. Over the course of 35 years, Ms. Lurier has helped build multiple organizations from the ground up. Most recently, at Centessa Pharmaceuticals (CNTA) and Triplet Therapeutics. Ms. Lurier earned a Bachelor of Science degree in Synthetic Organic Chemistry from the University of Massachusetts.
This person is not in any teams
This person is not in any offices
Carbon Biosciences
1 followers
Carbon Biosciences is expanding the therapeutic potential of gene therapy through its proprietary platform which leverages novel parvoviruses that have been pressure tested by nature to target specific tissues, carry a larger cargo, with minimal neutralizing immunity and the potential to re-dose. Founded by Longwood Fund and gene therapy pioneers John F. Engelhardt, Ph.D., and Robert M. Kotin, Ph.D., Carbon is expanding the gene therapy toolbox for the treatment of the world’s most devastating and difficult to treat diseases.